Publikationen in Zusammenarbeit mit Forschern von Queen's University Belfast (46)

2010

  1. High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK

    BMC Biochemistry, Vol. 11, Núm. 1

  2. Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP

    Journal of Biological Chemistry, Vol. 285, Núm. 10, pp. 6960-6969

2009

  1. Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients

    Pharmacogenomics, Vol. 10, Núm. 7, pp. 1177-1186

  2. IL7RA polymorphisms and chronic inflammatory arthropathies

    Tissue Antigens

2008

  1. IL7RA polymorphisms and susceptibility to multiple sclerosis [18]

    New England Journal of Medicine

  2. Interferon gamma allelic variants: Sex-biased multiple sclerosis susceptibility and gene expression

    Archives of Neurology, Vol. 65, Núm. 3, pp. 349-357

  3. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine

    British Journal of Clinical Pharmacology, Vol. 66, Núm. 4, pp. 517-528

  4. Refining genetic associations in multiple sclerosis

    The Lancet Neurology

  5. Signalling, inflammation and arthritis: Crossed signals: The role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity

    Rheumatology, Vol. 47, Núm. 6, pp. 771-776

2007

  1. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland

    Journal of Neuroimmunology, Vol. 187, Núm. 1-2, pp. 187-191

  2. Corrigendum to "Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans" [J. Neuroimmunol. 179 (2006) 108-116] (DOI:10.1016/j.jneuroim.2006.06.003)

    Journal of Neuroimmunology

  3. ITGA4 polymorphisms and susceptibility to multiple sclerosis

    Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 151-157

  4. Pharmacogenomics of Type I interferon therapy: A survey of response-modifying genes

    Cytokine and Growth Factor Reviews

  5. Study of polymorphisms in the interleukin-4 and IL-4 receptor genes in a population of Brazilian patients with multiple sclerosis

    Arquivos de Neuro-Psiquiatria, Vol. 65, Núm. 1, pp. 15-19

  6. The MHC2TA -168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies

    Tissue Antigens, Vol. 70, Núm. 3, pp. 247-251

  7. The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis

    Journal of Neuroimmunology, Vol. 183, Núm. 1-2, pp. 208-213

2006

  1. Celecoxib inhibits interleukin-12 αβ and β2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum

    Molecular Pharmacology, Vol. 69, Núm. 5, pp. 1579-1587

  2. Cytokine gene polymorphisms in multifactorial conditions

    CRC Press, pp. 1-459

  3. Multi-chaperone complexes regulate the folding of interferon-γ in the endoplasmic reticulum

    Cytokine, Vol. 33, Núm. 5, pp. 264-273

  4. Polymorphisms in the interleukin-4 and IL-4 receptor genes modify risk for chronic inflammatory arthropathies in women

    Experimental and Molecular Pathology, Vol. 81, Núm. 3, pp. 239-244